|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT00336154 |
|
Date of registration:
|
12/06/2006 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa
|
|
Scientific title:
|
Randomised Double Blind Crossover Placebo Controlled Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa |
|
Date of first enrolment:
|
March 3, 2006 |
|
Target sample size:
|
0 |
|
Recruitment status: |
Withdrawn |
|
URL:
|
https://clinicaltrials.gov/show/NCT00336154 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Double.
|
|
Phase:
|
Phase 4
|
|
|
Countries of recruitment
|
|
Israel
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- diagnosed as epidermolysis bullosa
- not pregnant
- active disease
- more than 5 bulla-
Exclusion Criteria:
- age less than 13
- known sensitivity to tetracyclin
- abnormal liver and kidney tests.
Age minimum:
13 Years
Age maximum:
60 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Epidermolysis Bullosa
|
|
Intervention(s)
|
|
Drug: tetracyclin
|
|
Primary Outcome(s)
|
|
no of blisters
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|